Cargando…
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing
BACKGROUND: Pharmacogenetics is involved in customizing therapy according to the genetic makeup of an individual, and is applicable for chemotherapy, radiotherapy as well as targeted therapy. Drug metabolizing enzymes (DMEs) involving both phase I, and phase II reactions are widely studied. Our stud...
Autores principales: | Aboul-Soud, Mourad A.M., Alzahrani, Alhussain J., Mahmoud, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783809/ https://www.ncbi.nlm.nih.gov/pubmed/33424349 http://dx.doi.org/10.1016/j.sjbs.2020.10.052 |
Ejemplares similares
-
Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
por: Aboul-Soud, Mourad A. M., et al.
Publicado: (2021) -
Detection of Novel Biallelic Causative Variants in COL7A1 Gene by Whole-Exome Sequencing, Resulting in Congenital Recessive Dystrophic Epidermolysis Bullosa in Three Unrelated Families
por: Fozia, Fozia, et al.
Publicado: (2022) -
Whole Exome Sequence Analysis for Inborn Errors of IL-12/IFN-γ Axis in Patient with Recurrent Typhoid Fever
por: Hassan, Faaiz ul, et al.
Publicado: (2023) -
Whole‐exome sequencing for variant discovery in blepharospasm
por: Tian, Jun, et al.
Publicado: (2018) -
Implementation and use of whole exome sequencing for metastatic solid cancer
por: Réda, Manon, et al.
Publicado: (2020)